review
focu
specif
role
defensin
antimicrobi
peptid
human
mucos
immun
excel
recent
review
cover
structur
genom
evolut
mechan
action
antimicrobi
peptid
refer
reader
extens
discuss
aspect
consid
topic
relat
action
antimicrobi
peptid
specif
mucos
site
gener
defensin
two
major
function
host
defens
direct
inhibit
pathogen
modul
innat
adapt
immun
respons
human
defensin
includ
hbd
express
wide
skin
mucos
epithelia
six
includ
hnp
epitheli
hbd
express
predominantli
mucos
epitheli
cell
contribut
initi
host
defens
infect
also
mainten
epitheli
integr
hnp
express
predominantli
neutrophil
lesser
extent
bone
cell
resid
recruit
inflam
infect
site
bodi
express
constitut
gener
packag
granul
azurophil
granul
neutrophil
hnp
small
intestin
paneth
cell
granul
hd
releas
degranul
hd
also
releas
epitheli
cell
mucos
site
eg
genitourinari
tract
hnp
gener
process
matur
peptid
prior
releas
wherea
hd
must
cleav
extracellular
proteas
achiev
matur
activ
form
gener
hbd
express
secret
epitheli
cell
rather
degranul
secret
matur
form
surfac
line
fluid
surround
cell
consid
hbd
review
although
least
two
other
describ
wide
express
constitut
manner
epitheli
cell
express
induc
small
degre
inflammatori
stimuli
epithelia
hbd
also
wide
express
epitheli
cell
express
induc
tissu
respons
infecti
inflammatori
stimuli
includ
similar
biolog
play
central
role
mucos
defens
well
like
defensin
member
larg
famili
cation
antimicrobi
peptid
express
mani
speci
antimicrobi
activ
mani
immunomodulatori
effect
cathelicidin
contain
signal
peptid
domain
antimicrobi
domain
produc
neutrophil
macrophag
variou
epitheli
cell
well
antimicrobi
domain
releas
cleavag
proteas
domain
term
gener
use
term
subsequ
review
also
consid
anoth
class
defensin
call
retrocyclin
cyclic
structur
express
nonhuman
primat
rhesu
macaqu
oliv
baboon
papio
anubi
human
express
mrna
lack
correspond
peptid
human
gene
contain
stop
codon
signal
sequenc
abort
translat
retrocyclin
synthet
human
peptid
whose
sequenc
base
found
human
gene
deft
also
antibacteri
antivir
activ
relev
review
therapeut
potenti
also
shown
recent
express
rescu
human
epitheli
cell
treatment
aminoglycosid
focu
major
mucos
system
includ
respiratori
tract
gastrointestin
tract
oral
caviti
genitourinari
tract
skin
eye
discuss
respiratori
tract
extens
gener
theme
concept
laid
mucosa
within
system
even
within
differ
local
within
mucos
system
eg
nasal
caviti
upper
lower
respiratori
tract
differ
function
bodi
differ
need
term
host
defens
site
normal
steril
other
contain
commens
bacteria
necess
full
justic
differ
domain
within
mucos
system
divers
role
defensin
play
within
specif
site
howev
hope
convey
extraordinari
detail
intricaci
system
evolv
allow
mucos
surfac
carri
job
allow
exchang
extern
environ
protect
us
myriad
pathogen
potenti
injuri
tabl
summar
major
known
associ
human
diseas
alter
defensin
studi
cf
reveal
complex
tri
determin
role
defensin
lung
diseas
children
cf
born
normal
lung
function
undergo
steadi
deterior
mark
recurr
respiratori
bacteri
viral
infect
chronic
lung
infect
organ
pseudomona
aeruginosa
burkholderia
cenocepacia
balf
cf
patient
shown
reduc
antibacteri
activ
appear
part
result
high
salt
concentr
fluid
inhibit
defensin
activ
infect
may
impair
cf
level
hbd
hnp
affect
gene
copi
number
highli
variabl
gene
encod
protein
howev
associ
found
hbd
copi
number
progress
cf
hbd
shown
proteolyt
degrad
cathepsin
present
balf
cf
patient
addit
lp
b
cenocepacia
render
resist
antimicrobi
peptid
henc
appear
impair
activ
impair
product
acceler
breakdown
hbd
cf
could
part
account
reduc
antibacteri
activ
defect
antibacteri
activ
fluid
also
demonstr
furthermor
increas
level
hnp
cf
balf
associ
persist
inflamm
infect
peptid
could
actual
promot
deleteri
inflamm
sever
way
includ
stimul
mucin
product
interf
activ
neutrophil
proteas
level
elev
concert
hnp
cf
inflammatori
lung
condit
eg
defici
act
concert
manner
reduc
level
stimul
product
note
instil
hnp
mous
lung
caus
inflamm
deterior
lung
function
find
suggest
condit
high
level
hnp
may
deleteri
contrast
recent
studi
show
hnp
releas
die
necrot
neutrophil
dampen
inflamm
vitro
vivo
probabl
inhibit
proinflammatori
cytokin
product
macrophag
promot
macrophag
phagocytosi
elev
level
found
diffus
panbronchiol
progress
inflammatori
diseas
also
associ
recurr
episod
lung
infect
similarli
elev
level
note
bronchiol
obliteran
complic
lung
transplant
elev
level
hnp
found
idiopath
pulmonari
fibrosi
ard
case
correl
degre
lung
inflamm
injuri
studi
obvious
need
determin
defensin
caus
inflamm
respons
insult
contribut
defensin
asthma
studi
extens
although
subject
asthma
increas
suscept
respiratori
viral
infect
interest
express
suppress
cytokin
lead
reduc
antimicrobi
activ
corticosteroid
treatment
also
reduc
antimicrobi
peptid
product
calv
bacteri
pneumonia
associ
elev
level
lung
fluid
blood
consequ
neutrophil
recruit
massiv
amount
hnp
also
present
acut
phase
pneumonia
extent
peptid
act
within
phagocyt
vacuol
releas
respiratori
fluid
determin
howev
high
level
eg
ugml
measur
blood
sepsi
balf
patient
bacteri
pneumonia
tuberculosi
unclear
defensin
process
remov
although
one
mechan
inhibit
hnp
lung
involv
arginin
residu
hnp
activ
also
inhibit
serum
protein
pathogen
bacteria
evolv
way
evad
kill
respiratori
antimicrobi
peptid
includ
modif
lp
structur
eg
b
cenocepacia
hinfluenza
secret
bacteri
surfac
protein
eg
protein
group
b
streptococcu
appear
play
import
role
host
defens
tuberculosi
african
american
shown
increas
suscept
tuberculosi
may
relat
low
level
vitamin
consequ
reduc
abil
macrophag
kill
tuberculosi
treatment
macrophag
tlr
agonist
increas
vitamin
receptor
result
increas
product
vitamin
gene
hnp
also
activ
mycobacteria
may
contribut
host
defens
mediat
macrophag
eosinophil
antimicrobi
peptid
like
play
import
role
respiratori
viral
infect
well
hnp
hd
retrocyclin
antivir
activ
iav
interest
treatment
increas
cathelicidin
product
mous
lung
treatment
result
improv
outcom
iav
infect
also
play
import
role
defens
iav
potenti
advers
effect
sever
respiratori
iav
sar
infect
associ
extens
neutrophil
influx
degrad
action
proteas
hnp
hnp
bind
strongli
gener
reduc
antivir
activ
caus
precipit
balf
shown
recent
retrocyclin
hbd
interfer
antivir
activ
rather
addit
effect
defensin
also
activ
varieti
respiratori
virus
includ
rsv
adenoviru
parainfluenza
viru
contribut
respiratori
epitheli
cell
respons
rhinoviru
tobacco
smoke
predispos
infect
emphysema
lung
cancer
recent
studi
demonstr
current
former
smoke
associ
reduc
level
pharyng
wash
sputum
patient
acut
pneumonia
note
smoke
chronic
obstruct
lung
diseas
also
associ
reduc
level
may
impair
innat
defens
studi
human
subject
ileal
crohn
diseas
cd
reveal
consist
evid
defici
diseas
pathogenesi
cd
chronic
inflammatori
condit
affect
small
bowel
especi
ileum
colon
lead
strictur
fistula
format
intestin
obstruct
cancer
main
approach
treatment
immun
suppress
surgeri
howev
longstand
observ
antibiot
caus
improv
chang
gut
bacteri
flora
adher
bacteria
small
intestin
line
found
cd
lead
hypothesi
primari
defect
antibacteri
defens
present
lead
chronic
inflamm
major
breakthrough
field
discoveri
link
frameshift
mutat
recruit
domain
subset
patient
cd
highli
express
paneth
cell
cytoplasm
receptor
bacteri
muramyl
peptid
compon
mani
bacteria
lead
activ
product
mutat
associ
mark
defici
link
specif
ileal
cd
colon
cd
ulcer
coliti
mice
show
decreas
subset
cryptdin
increas
suscept
listeria
infect
mutat
provid
genet
mechan
subset
patient
ileal
cd
howev
approxim
cd
patient
mutat
western
countri
rare
japanes
cd
patient
despit
defici
antibacteri
activ
intestin
mucos
extract
specif
paneth
cell
demonstr
major
patient
ileal
cd
defici
specif
paneth
cell
product
includ
lysozym
affect
find
led
search
explan
paneth
cell
cd
patient
recent
studi
demonstr
defici
ileal
cd
wnt
signal
involv
differenti
matur
paneth
cell
regul
specif
express
paneth
cell
mice
demonstr
mice
decreas
mrna
found
ileal
mucosa
ileal
cd
patient
decreas
correl
decreas
express
associ
express
inflamm
score
level
mutat
subject
defici
specif
ileal
colon
cd
heterozyg
mice
show
decreas
well
decreas
small
intestin
kill
aureu
e
coli
recent
group
demonstr
genet
associ
one
polymorph
promot
region
ileal
cd
genet
associ
independ
statu
henc
alter
appear
provid
anoth
genet
basi
paneth
cell
defici
ileal
cd
interest
associ
decreas
express
copi
number
made
colon
cd
suggest
form
diseas
also
relat
defect
host
defens
express
induc
colon
mucosa
activ
contrast
ulcer
coliti
express
elev
area
inflamm
express
elev
colon
cd
lumin
secret
colon
cd
reduc
antimicrobi
activ
similar
pattern
found
colon
cathelicidin
express
increas
inflam
area
ulcer
coliti
increas
colon
cd
henc
colon
cd
may
also
result
local
defici
antimicrobi
peptid
express
impair
epitheli
antibacteri
defens
mice
show
increas
adher
pathogen
intestin
bacteria
gut
support
concept
cathelicidin
contribut
intestin
host
defens
overal
result
highlight
import
defensin
part
initi
barrier
infect
mucos
surfac
appear
like
chronic
intestin
inflamm
character
differ
form
cd
therefor
reflect
simpl
hyperinflammatori
phenotyp
rather
failur
first
line
host
defens
lead
second
level
innat
adapt
immun
respons
fact
less
effect
rais
question
whether
chronic
inflammatori
condit
eg
asthma
result
failur
initi
defens
barrier
stomach
gastrointestin
site
normal
steril
apart
certain
highli
adapt
bacteria
h
pylori
infect
respons
varieti
human
diseas
includ
peptic
ulcer
diseas
gastric
cancer
includ
gastric
lymphoma
adenocarcinoma
human
popul
infect
h
pylori
major
asymptomat
therefor
import
goal
research
determin
factor
respons
colon
diseas
induct
h
pylori
one
import
factor
variat
pathogen
differ
h
pylori
strain
howev
variat
innat
defens
h
pylori
may
also
contribut
h
pylori
induc
hbd
mrna
protein
express
vitro
vivo
gastric
epithelia
strong
bactericid
activ
h
pylori
h
pylori
lp
appear
strong
stimulu
activ
gastric
epitheli
cell
impli
may
key
pathway
involv
respons
cell
bacteria
boughan
et
al
found
h
pylori
stimul
distinct
mechan
cell
stimul
wherea
pathway
cathelicidin
express
also
induc
gastric
epithelia
h
pylori
independ
antimicrobi
activ
bacteria
synerg
hbd
yet
known
event
relat
colon
diseas
induct
h
pylori
result
provid
basi
futur
clinic
research
tempt
specul
impair
earli
respons
may
allow
colon
ongo
inflamm
similar
find
cd
result
boughan
et
al
also
reveal
complex
regul
differ
defensin
author
specul
may
involv
earli
phase
host
respons
infect
wherea
induct
may
relat
later
phase
respons
egfr
h
pylori
infect
involv
wound
heal
note
express
defensin
mous
intestin
epithelium
correl
abil
inhibit
growth
salmonella
shigella
speci
gut
bacteri
pathogen
also
elicit
defensin
express
variabl
extent
intestin
epithelium
perhap
account
differ
pathogen
import
antimicrobi
peptid
host
defens
intestin
highlight
abil
import
intestin
bacteri
pathogen
counteract
product
action
peptid
exampl
cholera
toxin
labil
toxin
enteropathogen
e
coli
reduc
express
intestin
epitheli
cell
virul
shigella
flexneri
releas
plasmid
dna
turn
express
antimicrobi
peptid
epitheli
cell
monocyt
salmonella
speci
modifi
structur
lp
reduc
abil
antimicrobi
peptid
bind
kill
see
ref
excel
review
topic
role
antimicrobi
peptid
oral
caviti
subject
recent
excel
review
show
intrins
antivir
activ
saliva
iav
part
mediat
hnp
anoth
antimicrobi
peptid
histatin
although
inhibitor
contribut
well
fairli
high
level
hnp
saliva
normal
volunt
presum
deriv
neutrophil
edentul
subject
markedli
reduc
level
hnp
saliva
result
absenc
crevicula
site
neutrophil
ingress
may
account
increas
risk
oral
infect
subject
hiv
also
inhibit
saliva
hiv
appear
transmit
oral
contact
inhibit
hiv
concentr
found
normal
saliva
interest
level
found
reduc
saliva
subject
possibl
predispos
type
infect
morbu
kostmann
form
congenit
neutropenia
character
frequent
infect
includ
sever
periodont
although
neutrophil
count
increas
treatment
infect
persist
associ
defect
abil
neutrophil
produc
hnp
lack
saliva
intens
studi
host
defens
factor
may
contribut
protect
vulner
sexual
transmit
viral
infect
cation
antimicrobi
peptid
key
factor
contribut
abil
secret
inhibit
hiv
interest
direct
hiv
inhibitori
activ
also
bind
coreceptor
fluid
healthi
subject
inhibit
hsv
includ
protect
mice
lethal
infect
hsv
wherea
fluid
subject
less
inhibitori
inhibit
hsv
correl
level
hnp
fluid
increas
risk
hiv
hsv
infect
presenc
concurr
sexual
transmit
bacteri
viral
infect
bacteri
vaginosi
bv
character
chang
bacteri
flora
vagina
loss
normal
commens
lactobacillu
acquisit
bacteria
gardnerella
vaginali
valor
et
al
demonstr
antimicrobi
activ
vagin
fluid
patient
bv
reduc
bv
fluid
lower
concentr
hbd
hnp
compar
normal
control
patient
vulvovagin
candidiasi
low
level
hnp
correl
reduc
neutrophil
influx
henc
appear
defici
defensin
associ
bv
howev
intrins
defect
case
cd
defensin
level
rose
treatment
bv
low
level
defensin
may
contribut
acquisit
hiv
hsv
subject
reason
low
level
defensin
bv
may
relat
failur
g
vaginali
induc
immun
respons
instanc
g
vaginali
induc
vagin
epitheli
cell
wherea
induc
lactobacillu
jensenii
may
relat
lack
lp
low
concentr
peptidoglycan
coat
g
vaginali
bv
therefor
repres
exampl
commens
flora
provok
balanc
innat
immun
respons
limit
introduct
organ
wherea
superinfect
organ
induc
respons
exampl
bacteria
fail
induc
defensin
respons
allow
bacteria
persist
mucosa
instanc
aureu
strain
chronic
nasal
carrier
found
induc
nasal
mucosa
flexneri
inhibit
antimicrobi
peptid
express
gut
epithelia
henc
acquir
deficit
barrier
result
bacteri
infect
induc
vagin
secret
male
urethra
respons
infect
note
cleavag
precursor
hd
necessari
acquir
antimicrobi
activ
distinct
method
cleavag
found
studi
urethr
secret
subject
n
gonorrhoea
chlamydia
trachomati
infect
neutrophil
proteas
shown
affect
cleavag
also
produc
vagin
epitheli
cell
respons
n
gonorrhoea
infect
although
hnp
hbd
retrocyclin
inhibit
hiv
surpris
find
actual
increas
hiv
infect
cell
effect
mediat
direct
interact
viru
occur
purifi
peptid
supernat
n
vagin
epitheli
cell
effect
occur
hd
concentr
although
level
hd
vagin
lavag
less
lavag
probabl
dilut
consider
local
concentr
may
much
higher
interest
futur
determin
subject
nod
mutat
also
reduc
hd
level
mucos
site
intestin
whether
associ
chang
diseas
suscept
note
hnp
level
consider
higher
urethr
secret
henc
effect
may
predomin
effect
hd
instanc
urethr
level
hnp
particularli
elev
n
gonorrhoea
infect
respect
find
promot
hiv
infect
unexpect
found
contrast
hd
inhibitori
iav
import
determin
reason
diverg
effect
hd
infect
two
envelop
virus
anoth
paradox
find
secret
contain
high
level
hnp
contribut
activ
fluid
associ
one
studi
increas
risk
hiv
transmiss
relat
fact
sampl
came
subject
sexual
transmit
bacteri
infect
case
factor
promot
hiv
transmiss
presum
outweigh
impact
increas
antimicrobi
peptid
interest
increas
hbd
gene
copi
number
associ
reduc
risk
hiv
infect
preliminari
studi
studi
kind
interest
mice
develop
mice
show
increas
carriag
bacteria
bladder
similarli
mice
greater
suscept
bacteri
urinari
tract
infect
bk
viru
nonenvelop
polyomaviru
establish
lifelong
infect
human
popul
gener
infect
asymptomat
becom
problem
immunocompromis
host
caus
hemorrhag
cystiti
kidney
infect
lead
kidney
transplant
reject
recent
studi
demonstr
act
directli
virion
part
viral
aggreg
note
similarli
report
aggreg
iav
defensin
futur
studi
may
determin
differ
express
account
suscept
subject
complic
bk
infect
immun
suppress
papillomaviru
infect
link
genit
wart
cervic
penil
anal
head
neck
cancer
hnp
shown
strong
antivir
activ
human
papillomavirus
vitro
wherea
hbd
lack
activ
shown
anoth
studi
mediat
recruit
dc
preneoplast
epitheli
lesion
induc
papillomaviru
henc
defensin
may
modul
immun
respons
cancer
preneoplast
lesion
possibl
antimicrobi
peptid
protect
prostat
carcinoma
instanc
prostat
cancer
associ
loss
express
induc
cell
death
prostat
cancer
cell
line
contrast
evid
facilit
develop
ovarian
cancer
complex
regul
antimicrobi
peptid
express
skin
relev
varieti
import
skin
diseas
atop
dermat
character
increas
frequenc
skin
infect
viral
bacteri
fungal
organ
express
reduc
greatli
atop
dermat
lesion
compar
normal
control
psoriasi
peptid
increas
decreas
antimicrobi
peptid
express
independ
recent
steroid
use
syndrom
primari
immunodefici
subject
atopi
recurr
staphylocc
skin
lung
infect
condit
found
relat
defect
cell
differenti
rais
question
infect
confin
princip
lung
skin
recent
studi
demonstr
may
relat
fact
keratinocyt
bronchial
epitheli
cell
contrast
epithelia
requir
classic
cytokin
gener
chemokin
antimicrobi
peptid
chronic
skin
ulcer
found
low
level
express
well
perhap
reflect
import
wound
heal
note
psoriasi
character
markedli
increas
express
case
may
contribut
diseas
pathogenesi
bind
result
autoimmun
respons
direct
dc
interest
hbd
gene
copi
number
increas
psoriasi
serum
level
hbd
propos
marker
diseas
increas
concentr
also
found
promot
inflamm
roseacea
glucocorticoid
elev
result
psycholog
stress
mice
caus
cramp
mous
skin
result
greater
suscept
streptococc
skin
infect
psycholog
stress
predispos
respiratori
infect
well
would
interest
determin
part
mediat
decreas
antimicrobi
peptid
express
lung
egfr
inhibitor
use
increasingli
treatment
cancer
principl
toxic
dermatolog
includ
rash
fissur
skin
interest
determin
toxic
relat
inhibit
defensin
product
skin
eye
anoth
site
effect
host
defens
minim
inflamm
import
p
aeruginosa
import
organ
capabl
caus
destruct
infect
cornea
use
mous
model
corneal
infect
pseudomona
infect
found
import
reduc
bacteri
count
neutrophil
infiltr
also
modul
express
varieti
inflammatori
cytokin
reduc
activ
although
also
express
cornea
silenc
alter
infect
inflamm
tear
fluid
also
contain
inhibit
p
aeruginosa
infect
mice
henc
anoth
site
like
respiratori
tract
defensin
may
interact
eye
also
potenti
portal
entri
iav
site
viral
infect
applic
shown
protect
kerat
although
discuss
depth
potenti
therapeut
use
defensin
possibl
relev
review
defensin
potenti
therapi
given
antimicrobi
antivir
activ
fact
synthes
minor
modif
enhanc
activ
direct
applic
site
skin
mucosa
treatment
wound
infect
interest
particularli
condit
antimicrobi
peptid
gener
reduc
one
concern
direct
applic
defensin
would
possibl
induc
excess
inflamm
occur
instil
hnp
lung
retrocyclin
interest
hiv
therapi
strongli
inhibit
viral
replic
found
retrocyclin
strong
antivir
activ
iav
unlik
hnp
interfer
antivir
activ
despit
bind
henc
retrocyclin
may
better
candid
hnp
instil
respiratori
tract
recent
studi
demonstr
reduc
weight
loss
mortal
mice
treat
retrocyclin
intranas
instil
min
infect
version
sar
coronaviru
surprisingli
protect
result
inhibit
viral
replic
model
retrocyclin
induc
level
inflamm
lung
although
reduc
gener
proinflammatori
cytokin
trigger
viru
henc
retrocyclin
may
exert
benefici
effect
modul
inflammatori
respons
lung
anoth
fascin
recent
find
retrocyclin
produc
human
secret
respons
aminoglycosid
treatment
treatment
diseas
direct
applic
defensin
may
impract
eg
deliv
defensin
treatment
inflammatori
bowel
diseas
adenovir
vector
deliveri
antimicrobi
peptid
test
anim
model
mix
result
anoth
approach
would
increas
endogen
defensin
gener
use
known
regulatori
stimuli
mous
model
administr
increas
defensin
cathelicidin
gener
improv
outcom
iav
infect
vascular
endotheli
growth
factor
promot
bd
product
lung
result
improv
outcom
rsv
infect
import
vitamin
gener
aspect
innat
defens
indic
measur
vitamin
level
supplement
could
import
improv
outcom
infect
one
gener
theme
emerg
studi
defensin
host
defens
protein
success
initi
barrier
invas
pathogen
prevent
deleteri
inflamm
breakdown
function
initi
barrier
lead
infect
also
chronic
inflammatori
condit
obviou
inflammatori
bowel
diseas
could
account
varieti
condit
gastric
diseas
induc
h
pylori
inflammatori
diseas
lung
interest
regard
bd
imbed
physiolog
process
wound
heal
angiogenesi
addit
role
defens
infect
reminisc
role
surfact
protein
lung
phospholipid
metabol
well
host
defens
anoth
recur
theme
pathogen
bacteria
evolv
varieti
mechan
circumv
immun
creat
invas
infect
import
subject
futur
studi
includ
defensin
interact
compon
innat
defens
sinc
clearli
act
isol
preliminari
studi
explor
question
studi
need
furthermor
current
hard
determin
rel
import
direct
antimicrobi
antivir
effect
defensin
compar
immunomodulatori
effect
mani
instanc
henc
import
focu
futur
investig
